Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.
Authors: Douillard, J. Y.1, Siena, S.2, Cassidy, J.3, Tabernero, J.4, Burkes, R.5, Barugel, M.6, Humblet, Y.7, Bodoky, G.8, Cunningham, D.9, Jassem, J.10, Rivera, F.11, Kocákova, I.12, Ruff, P.13, Błasińska-Morawiec, M.14, Šmakal, M.15, Canon, J. L.16, Rother, M.17, Oliner, K. S.18, Tian, Y.19, Xu, F.19
Source: Annals of Oncology. Jul2014, Vol. 25 Issue 7, p1346-1355. 10p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdu141